Literature DB >> 25985176

The role of the tumor microenvironment in HIV-associated lymphomas.

Joseph G Taylor1, Konstantinos Liapis1, John G Gribben1.   

Abstract

There has been considerable interest in the role of the lymphoma microenvironment. Despite the use of highly active antiretroviral therapy (HAART), AIDS-related diffuse large-B-cell lymphoma remains common and HIV-relatedHIV-associated classical Hodgkin's lymphoma is increasing in incidence. Less is known about the impact HIV and HAART have on the lymphoma microenvironment. AIDS-related diffuse large B-cell lymphoma is highly angiogenic, demonstrates increased lymphoblastic histology, proliferation, increased activated cytotoxic T cells, reduced CD4(+) and FOXP3(+) T cells, but no differences in tumor-associated macrophages. Early initiation of HAART improves immunosurveillance, but cases without viral antigens appear able to avoid immunologic reaction. Increased T cell infiltrates seen with HAART treatment in HIV-related classical Hodgkin's lymphoma may contribute to malignant cell growth.

Entities:  

Keywords:  HIV-related diffuse large B-cell lymphoma; Hodgkin's lymphoma; Tat; angiogenesis; immunosurveillance; impact of highly active antiretroviral therapy; p17; tumor microenvironment

Mesh:

Year:  2015        PMID: 25985176      PMCID: PMC4533913          DOI: 10.2217/bmm.15.13

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  55 in total

1.  Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.

Authors:  Paul Greaves; Andrew Clear; Andrew Owen; Sameena Iqbal; Abigail Lee; Janet Matthews; Andrew Wilson; Maria Calaminici; John G Gribben
Journal:  Blood       Date:  2013-09-04       Impact factor: 22.113

2.  Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP.

Authors:  Rita Coutinho; Andrew J Clear; Emanuele Mazzola; Andrew Owen; Paul Greaves; Andrew Wilson; Janet Matthews; Abigail Lee; Rute Alvarez; Maria Gomes da Silva; José Cabeçadas; Donna Neuberg; Maria Calaminici; John G Gribben
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

3.  Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity.

Authors:  P Scheidegger; W Weiglhofer; S Suarez; S Console; J Waltenberger; M S Pepper; R Jaussi; K Ballmer-Hofer
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

4.  A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.

Authors:  Mark Bower; Brian Gazzard; Sundhiya Mandalia; Tom Newsom-Davis; Christina Thirlwell; Tony Dhillon; Anne Marie Young; Tom Powles; Andrew Gaya; Mark Nelson; Justin Stebbing
Journal:  Ann Intern Med       Date:  2005-08-16       Impact factor: 25.391

5.  HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.

Authors:  Francesca Caccuri; Cinzia Giagulli; Antonella Bugatti; Anna Benetti; Giulio Alessandri; Domenico Ribatti; Stefania Marsico; Paola Apostoli; Mark A Slevin; Marco Rusnati; Carlos A Guzman; Simona Fiorentini; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

6.  Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.

Authors:  Sergio A Quezada; Tyler R Simpson; Karl S Peggs; Taha Merghoub; Jelena Vider; Xiaozhou Fan; Ronald Blasberg; Hideo Yagita; Pawel Muranski; Paul A Antony; Nicholas P Restifo; James P Allison
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

Review 7.  Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth.

Authors:  Cecilia Sgadari; Paolo Monini; Giovanni Barillari; Barbara Ensoli
Journal:  Lancet Oncol       Date:  2003-09       Impact factor: 41.316

8.  Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.

Authors:  Satish Gopal; Monita R Patel; Elizabeth L Yanik; Stephen R Cole; Chad J Achenbach; Sonia Napravnik; Greer A Burkholder; Erin G Reid; Benigno Rodriguez; Steven G Deeks; Kenneth H Mayer; Richard D Moore; Mari M Kitahata; Joseph J Eron; Kristy L Richards
Journal:  J Natl Cancer Inst       Date:  2013-07-26       Impact factor: 13.506

9.  Immunological and virological changes associated with decline in CD4/CD8 ratios in lymphoid organs of SIV-infected macaques.

Authors:  Y J Rosenberg; P M Zack; E C Leon; B D White; S F Papermaster; E Hall; J J Greenhouse; G A Eddy; M G Lewis
Journal:  AIDS Res Hum Retroviruses       Date:  1994-07       Impact factor: 2.205

10.  Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma.

Authors:  Sylvia Hartmann; Christina Jakobus; Benjamin Rengstl; Claudia Döring; Sebastian Newrzela; Hans-Reinhard Brodt; Timo Wolf; Martin-Leo Hansmann
Journal:  Mod Pathol       Date:  2013-01-11       Impact factor: 7.842

View more
  6 in total

1.  Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis.

Authors:  Pietro Mazzuca; Stefania Marsico; Kai Schulze; Stefania Mitola; Marina C Pils; Cinzia Giagulli; Carlos A Guzman; Arnaldo Caruso; Francesca Caccuri
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  Altered mucosal immunity in HIV-positive colon adenoma: decreased CD4+ T cell infiltration is correlated with nadir but not current CD4+ T cell blood counts.

Authors:  Yasuo Matsubara; Yasunori Ota; Yukihisa Tanaka; Tamami Denda; Yasuki Hijikata; Narikazu Boku; Lay Ahyoung Lim; Yoshihiro Hirata; Giichiro Tsurita; Eisuke Adachi; Hiroshi Yotsuyanagi
Journal:  Int J Clin Oncol       Date:  2022-05-29       Impact factor: 3.850

3.  Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.

Authors:  Riccardo Dolcetti; Cinzia Giagulli; Wangxiao He; Marina Selleri; Francesca Caccuri; Lindsay M Eyzaguirre; Pietro Mazzuca; Silvia Corbellini; Federica Campilongo; Stefania Marsico; Emanuela Giombini; Elena Muraro; Gabriella Rozera; Paolo De Paoli; Antonino Carbone; Maria Rosaria Capobianchi; Giuseppe Ippolito; Simona Fiorentini; William A Blattner; Wuyuan Lu; Robert C Gallo; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

4.  Human immunodeficiency virus Tat-TIP30 interaction promotes metastasis by enhancing the nuclear translocation of Snail in lung cancer cell lines.

Authors:  Yu-Peng Liu; Chao-Hsiung Chen; Chia-Hung Yen; Chun-Wei Tung; Chao-Ju Chen; Yi-Ming A Chen; Ming-Shyan Huang
Journal:  Cancer Sci       Date:  2018-09-03       Impact factor: 6.716

Review 5.  Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind.

Authors:  Maria Isaguliants; Ekaterina Bayurova; Darya Avdoshina; Alla Kondrashova; Francesca Chiodi; Joel M Palefsky
Journal:  Cancers (Basel)       Date:  2021-01-15       Impact factor: 6.639

6.  A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection.

Authors:  Sarah Nietz; Daniel S O'Neil; Oluwatosin Ayeni; Wenlong Carl Chen; Maureen Joffe; Judith S Jacobson; Alfred I Neugut; Paul Ruff; Witness Mapanga; Ines Buccimazza; Urishka Singh; Sharon Čačala; Laura Stopforth; Boitumelo Phakathi; Tobias Chirwa; Herbert Cubasch
Journal:  Breast Cancer Res Treat       Date:  2020-09-01       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.